Shanghai Hile Bio-Technology Balance Sheet Health
Financial Health criteria checks 4/6
Shanghai Hile Bio-Technology has a total shareholder equity of CN¥1.2B and total debt of CN¥70.0M, which brings its debt-to-equity ratio to 5.9%. Its total assets and total liabilities are CN¥1.6B and CN¥464.5M respectively.
Key information
5.9%
Debt to equity ratio
CN¥70.00m
Debt
Interest coverage ratio | n/a |
Cash | CN¥338.47m |
Equity | CN¥1.18b |
Total liabilities | CN¥464.46m |
Total assets | CN¥1.65b |
Recent financial health updates
No updates
Financial Position Analysis
Short Term Liabilities: 603718's short term assets (CN¥556.1M) exceed its short term liabilities (CN¥398.8M).
Long Term Liabilities: 603718's short term assets (CN¥556.1M) exceed its long term liabilities (CN¥65.6M).
Debt to Equity History and Analysis
Debt Level: 603718 has more cash than its total debt.
Reducing Debt: 603718's debt to equity ratio has increased from 4.9% to 5.9% over the past 5 years.
Debt Coverage: 603718's debt is well covered by operating cash flow (37.1%).
Interest Coverage: Insufficient data to determine if 603718's interest payments on its debt are well covered by EBIT.